ASCEND
BY NTHRYS
🎓

You are exploring a lot!

Register free to continue exploring ASCEND — access research frontiers, workshops, training modules and more.

Register Free →

NTHRYS › PhD Assistance › Medicinal Chemistry

Medicinal Chemistry

Field
▾
Category
▾

Medicinal Chemistry

Select a category to explore research frontiers

Structure-Based Drug Design and Molecular Modeling
Explore frontiers →
Fragment-Based Lead Discovery and Optimization
Explore frontiers →
Allosteric Modulation of Protein Targets
Explore frontiers →
Proteolysis Targeting Chimeras Technology
Explore frontiers →
Kinase Inhibitor Development and Selectivity
Explore frontiers →
G Protein-Coupled Receptor Ligand Discovery
Explore frontiers →
Ion Channel Modulation and Drug Design
Explore frontiers →
Natural Product-Inspired Synthetic Chemistry
Explore frontiers →
Prodrug Design and Metabolic Activation
Explore frontiers →
Blood-Brain Barrier Penetration Optimization
Explore frontiers →
Bioisosteric Replacement and Molecular Mimicry
Explore frontiers →
Protein-Protein Interaction Modulators
Explore frontiers →
Antibody Drug Conjugate Chemistry
Explore frontiers →
Epigenetic Modulator Discovery and Development
Explore frontiers →
Fluorine Chemistry in Drug Development
Explore frontiers →
Macrocyclic Drug Design and Conformational Analysis
Explore frontiers →
Copper-Catalyzed Azide-Alkyne Cycloaddition
Explore frontiers →
Photodynamic Therapy Agent Development
Explore frontiers →
Radioligand Development for Diagnostic Imaging
Explore frontiers →
Enzyme Inhibitor Kinetics and Mechanism
Explore frontiers →
Polypharmacology and Multi-Target Drug Design
Explore frontiers →
Privileged Structures in Medicinal Chemistry
Explore frontiers →
Deuteration and Isotopic Labeling Strategies
Explore frontiers →
Covalent Inhibitor Design and Selectivity
Explore frontiers →
Metabolism and Pharmacokinetic Prediction
Explore frontiers →
Hepatotoxicity Risk Assessment and Mitigation
Explore frontiers →
Nuclear Receptor Ligand Development
Explore frontiers →
Antimicrobial and Antifungal Agent Design
Explore frontiers →
Antiviral Agent Development Against Resistant Strains
Explore frontiers →
Cancer Immunotherapy Small Molecule Agonists
Explore frontiers →
Checkpoint Inhibitor Development and Engineering
Explore frontiers →
Chemokine Receptor Antagonist Design
Explore frontiers →
Neuroinflammation Target Identification and Modulation
Explore frontiers →
Tau Protein Aggregation Inhibitors
Explore frontiers →
Amyloid-Beta Targeting Therapeutics
Explore frontiers →
Diabetes and Metabolic Disorder Therapeutics
Explore frontiers →
Lipid-Lowering Agent Development Strategy
Explore frontiers →
Thrombin and Factor Xa Inhibitor Design
Explore frontiers →
Antimalarial Compound Development and Resistance
Explore frontiers →
Neglected Tropical Disease Drug Discovery
Explore frontiers →
Tuberculosis Drug Resistance and New Agents
Explore frontiers →
Combinatorial Chemistry Library Generation
Explore frontiers →
Virtual Screening and Chemoinformatic Prediction
Explore frontiers →
Pharmacophore Modeling and 3D QSAR
Explore frontiers →
Ligand Binding Affinity Prediction Methods
Explore frontiers →
High-Throughput Screening Campaign Design
Explore frontiers →
Hit-to-Lead Optimization and SAR Development
Explore frontiers →
Oral Bioavailability Enhancement Techniques
Explore frontiers →
Aqueous Solubility and Supersaturation Control
Explore frontiers →
Chiral Drug Development and Stereoisomer Selectivity
Explore frontiers →
Artificial Intelligence-Driven Molecular Generation
Explore frontiers →
Membrane Protein Stabilization and Crystallization
Explore frontiers →
Selective Estrogen Receptor Modulator Chemistry
Explore frontiers →
Tight Binding Inhibitor Discovery Methods
Explore frontiers →
RNA-Targeting Small Molecule Therapeutics
Explore frontiers →
Mitochondrial Dysfunction Targeted Drug Design
Explore frontiers →
Intrinsically Disordered Protein Modulators
Explore frontiers →
Quantum Mechanics in Drug Design Applications
Explore frontiers →
Bile Acid Receptor Agonist Development
Explore frontiers →
Immunogenic Cell Death Inducer Chemistry
Explore frontiers →
Lactam Ring-Fused Privileged Scaffolds
Explore frontiers →
Peroxisome Proliferator-Activated Receptor Ligands
Explore frontiers →
Lysosomal Storage Disease Enzyme Replacement
Explore frontiers →
Bromodomain and Extraterminal Inhibitors
Explore frontiers →
Transient Receptor Potential Channel Modulators
Explore frontiers →
Wnt Signaling Pathway Inhibitor Development
Explore frontiers →
Histone Deacetylase Isoform Selectivity
Explore frontiers →
Ferroptosis Inducer and Inhibitor Design
Explore frontiers →
Glycogen Synthase Kinase-3 Inhibitor Chemistry
Explore frontiers →
Soluble Epoxide Hydrolase Inhibition
Explore frontiers →
Aryl Hydrocarbon Receptor Modulator Development
Explore frontiers →
Sphingosine-1-Phosphate Receptor Modulators
Explore frontiers →
Metallo-Beta-Lactamase Inhibitor Strategy
Explore frontiers →
Oncogenic KRAS Mutation Selective Inhibition
Explore frontiers →
Estrogen-Related Receptor Gamma Antagonists
Explore frontiers →
P2X and P2Y Purinergic Receptor Ligands
Explore frontiers →
Notch Signaling Pathway Inhibitor Chemistry
Explore frontiers →
Formyl Peptide Receptor Agonist Discovery
Explore frontiers →
Ubiquitin-Proteasome System Modulators
Explore frontiers →
Complement C5 Inhibitor Optimization
Explore frontiers →
Histone Acetyltransferase Inhibitor Library
Explore frontiers →
Nod-Like Receptor Inflammasome Inhibitors
Explore frontiers →
Oxytocin and Vasopressin Receptor Ligands
Explore frontiers →
Phosphodiesterase-10A Selective Inhibitors
Explore frontiers →
Leucine-Rich Repeat Kinase-2 Modulation
Explore frontiers →
Sigma-1 Receptor Ligand Pharmacology
Explore frontiers →
Muscarinic Acetylcholine Receptor M4 Agonists
Explore frontiers →
Organic Anion Transporter Inhibitor Design
Explore frontiers →
Angiotensin-Converting Enzyme-Related Carboxypeptidase
Explore frontiers →
Transglutaminase-2 Inhibitor Discovery
Explore frontiers →
Methionine Aminopeptidase-2 Inhibition
Explore frontiers →
Neuropeptide Y Receptor Selective Agonists
Explore frontiers →
Heat Shock Protein 90 Alpha Inhibitor Chemistry
Explore frontiers →
Succinate Dehydrogenase Inhibitor Mechanism
Explore frontiers →
Solute Carrier Family Transporter Modulation
Explore frontiers →
Pituitary Adenylyl Cyclase-Activating Peptide Receptor
Explore frontiers →
Interferon Regulatory Factor Modulator Chemistry
Explore frontiers →
Cyclin-Dependent Kinase-4/6 Selective Inhibitors
Explore frontiers →
Lysine-Specific Histone Demethylase Inhibitors
Explore frontiers →
Transforming Growth Factor-Beta Signaling Inhibition
Explore frontiers →
Targeted Protein Degradation Beyond PROTACs
Explore frontiers →
Intrinsically Disordered Protein Targeting
Explore frontiers →
Membrane Protein Structure Elucidation Chemistry
Explore frontiers →
Targeted Lysosomal Drug Delivery Systems
Explore frontiers →
Mitochondrial-Targeting Therapeutic Compounds
Explore frontiers →
Extracellular Matrix Protein Modulators
Explore frontiers →
Lipid Peroxidation and Ferroptosis Modulators
Explore frontiers →
Metabolite Mimicry and Competitive Inhibition
Explore frontiers →
Artificial Metalloenzyme Substrate Development
Explore frontiers →
Circadian Rhythm Modulation Therapeutics
Explore frontiers →
Senolytic and Senomorphic Drug Discovery
Explore frontiers →
Autophagy Flux Modulation and Regulation
Explore frontiers →
Immune Checkpoint Ligand Engineering
Explore frontiers →
Innate Immune Pattern Recognition Agonists
Explore frontiers →
Fibrotic Disease Target Identification Chemistry
Explore frontiers →
Thromboinflammation Modulator Development
Explore frontiers →
Bacterial Virulence Factor Inhibitors
Explore frontiers →
Fungal Cell Wall Synthesis Inhibition
Explore frontiers →
Parasite Metabolic Pathway Exploitation
Explore frontiers →
Oncogenic Fusion Protein Inhibitors
Explore frontiers →
Synthetic Lethal Target Identification Chemistry
Explore frontiers →
Immunogenic Cell Death Inducer Development
Explore frontiers →
RNA Modification Enzyme Inhibitors
Explore frontiers →
Protein Aggregation and Disaggregation Modulators
Explore frontiers →
Metabolic Reprogramming Cancer Therapeutics
Explore frontiers →
Oxidative Stress Response Pathway Modulation
Explore frontiers →
Angiogenesis and Vascular Development Inhibitors
Explore frontiers →
Lymphatic Function Enhancement Therapeutics
Explore frontiers →
Barrier Function Restoration in Inflammation
Explore frontiers →
Microbial Dysbiosis Correction Chemistry
Explore frontiers →
Xenobiotic Metabolism Inhibitor Design
Explore frontiers →
Transporter-Mediated Drug Uptake Enhancement
Explore frontiers →
Carrier-Mediated Efflux Liability Reduction
Explore frontiers →
Tissue-Specific Drug Accumulation Optimization
Explore frontiers →
Off-Target Toxicity Prediction and Mitigation
Explore frontiers →
Genotoxicity and Mutagenicity Assessment Chemistry
Explore frontiers →
Phenotypic Screening Hit Validation Chemistry
Explore frontiers →
Cell-Based Potency Assay Development
Explore frontiers →
Conformational Selectivity and Dynamics Targeting
Explore frontiers →
Enthalpy-Entropy Compensation in Binding
Explore frontiers →
Water-Mediated Interactions and Displacement
Explore frontiers →
Salt Bridge Engineering and Ionizable Groups
Explore frontiers →
Halogen Bonding in Drug Design
Explore frontiers →
Metallodrug Development and Coordination Chemistry
Explore frontiers →
Boron-Containing Inhibitor Development
Explore frontiers →
Silicon Bioisostere Applications in Drug Design
Explore frontiers →
Polycyclic Aromatic Hydrocarbon Pharmacology
Explore frontiers →
Heterocyclic Core Synthesis and Diversification
Explore frontiers →
Multiparametric Compound Optimization Strategies
Explore frontiers →
Selective Estrogen Receptor Modulator Design
Explore frontiers →
Aromatase Inhibitor Optimization for Cancer Therapy
Explore frontiers →
Histone Deacetylase Inhibitor Development
Explore frontiers →
DNA Methyl Transferase Inhibitor Chemistry
Explore frontiers →
Bromodomain-Containing Protein Antagonists
Explore frontiers →
Metallo-Beta-Lactamase Inhibitor Design
Explore frontiers →
Topoisomerase Poison and Catalytic Inhibitor Development
Explore frontiers →
Poly-ADP-Ribose Polymerase Inhibitor Strategies
Explore frontiers →
Histone Acetyltransferase Activator Development
Explore frontiers →
Melatonin Receptor Agonist and Antagonist Optimization
Explore frontiers →
Peroxisome Proliferator-Activated Receptor Selective Modulation
Explore frontiers →
Retinoid X Receptor Ligand Discovery
Explore frontiers →
Voltage-Gated Calcium Channel Selective Inhibition
Explore frontiers →
Potassium Channel Opener and Closer Discovery
Explore frontiers →
Ligand-Gated Ion Channel Positive Allosteric Modulation
Explore frontiers →
Nicotinic Acetylcholine Receptor Subtype Selectivity
Explore frontiers →
Muscarinic M1 Receptor Agonist Development
Explore frontiers →
Phosphodiesterase Inhibitor Isoform Selectivity
Explore frontiers →
Adenosine Receptor Subtype Selective Ligands
Explore frontiers →
Serotonin Receptor Biased Signaling Modulators
Explore frontiers →
Dopamine Receptor D1/D2 Functional Selectivity
Explore frontiers →
Opioid Receptor Functional Selectivity and Bias
Explore frontiers →
Bradykinin Receptor Antagonist Development
Explore frontiers →
Leukotriene Receptor Antagonist and 5-LOX Inhibition
Explore frontiers →
Prostaglandin Receptor Selective Modulation
Explore frontiers →
Complement Component C5a Receptor Antagonism
Explore frontiers →
Toll-Like Receptor Agonist and Antagonist Chemistry
Explore frontiers →
Sphingosine-1-Phosphate Receptor Modulator Discovery
Explore frontiers →
Lysophosphatidic Acid Receptor Antagonist Design
Explore frontiers →
P2Y Purinergic Receptor Selective Modulation
Explore frontiers →
Metabotropic Glutamate Receptor Allosteric Modulation
Explore frontiers →
Transforming Growth Factor-Beta Signaling Inhibitors
Explore frontiers →
Bone Morphogenetic Protein Receptor Modulation
Explore frontiers →
Notch Signaling Pathway Inhibitor Development
Explore frontiers →
Wnt Signaling Pathway Modulator Chemistry
Explore frontiers →
Hedgehog Signaling Inhibitor Optimization
Explore frontiers →
JAK-STAT Selective Kinase Inhibitor Design
Explore frontiers →
PI3K-AKT-mTOR Pathway Inhibitor Strategies
Explore frontiers →
Receptor Tyrosine Kinase Inhibitor Selectivity Profiling
Explore frontiers →
BRAF V600E and MEK Inhibitor Combination Strategies
Explore frontiers →
Cyclin-Dependent Kinase Selective Inhibition
Explore frontiers →
Anaplastic Lymphoma Kinase Inhibitor Development
Explore frontiers →
Fibroblast Growth Factor Receptor Selective Inhibition
Explore frontiers →
Rearranged During Transfection Tyrosine Kinase Inhibition
Explore frontiers →
Tropomyosin Receptor Kinase Agonist Development
Explore frontiers →
C-SRC Tyrosine Kinase Selective Inhibition
Explore frontiers →
Focal Adhesion Kinase Inhibitor Chemistry
Explore frontiers →
Drug-Transporter Inhibitor and Modulation Strategy
Explore frontiers →
Cytochrome P450 Selective Inhibition and Induction
Explore frontiers →
Metabolic Stability Enhancement through Ring Isosteres
Explore frontiers →
Targetable Nanoparticle Drug Delivery Systems
Explore frontiers →